Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Sells $244,842.48 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 2,104 shares of the stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $116.37, for a total transaction of $244,842.48. Following the transaction, the chief financial officer now directly owns 20,647 shares of the company’s […]
More Stories
ICE Agent Shot, Killed Protester Who Drove Vehicle Toward Officers in Minnesota: DHS
By Jacki Thrapp A U.S. Immigration and Customs Enforcement officer in Minnesota shot and killed an anti-ICE protester during an...
A New Dawn for Venezuela: How the Capture of Nicolás Maduro Paves the Way for Prosperity, Justice, and Global Stability
By Stephen Zogopoulos, USNN World News In a bold and decisive move that has reshaped the geopolitical landscape of the...
With GDP up 4.3%, 5% Gains Are Likely in 2026
By Louis Navellier Commentary My 5% GDP growth prediction raised some eyebrows during a recent appearance on Fox Business News. However,...
After Maduro’s Arrest, CCP Censors Let Anti-American Hatred Spread Online—By Design: Analysts
By Michael Zhuang News Analysis After U.S. special forces captured Venezuelan leader Nicolás Maduro to stand trial in federal court,...
The Truth About Venezuela Under Socialism, From Those Who Fled It
By Troy Myers DORAL, Fla.—Zarai Maza survived a torched vehicle and a horrific car crash after peacefully protesting the Venezuelan...
DOJ Sues Arizona, Connecticut for Failing to Hand Over Voter Rolls
By Matthew Vadum The U.S. Department of Justice (DOJ) said on Jan. 6 that it is suing Arizona and Connecticut...